Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | PYGL | P06737 | 2/20 | 0.31 |
| ▸ | PYGB | P11216 | 1/20 | 0.31 |
| ▸ | PYGM | P11217 | 1/20 | 0.31 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.30 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3655173 | 0.82 | PYGB (0.37) | PYGLPYGBPYGMSLC5A2 | |
| SCHEMBL27599840 | 0.81 | MEN1 (0.38) | PYGLPYGBPYGM | |
| SCHEMBL3659834 | 0.73 | L3MBTL1 (0.46) | CA1CA2CA7 | |
| SCHEMBL28003456 | 0.72 | PYGB (0.33) | PYGLPYGBPYGM | |
| SCHEMBL29129214 | 0.72 | PYGB (0.33) | PYGLPYGBPYGM | |
| SCHEMBL27616429 | 0.72 | PYGB (0.33) | PYGLPYGBPYGM | |
| Water SCHEMBL27597578 | 0.71 | MEN1 (0.32) | PYGLPYGBPYGM | |
| SCHEMBL27836677 | 0.71 | PYGB (0.33) | PYGLPYGBPYGM | |
| SCHEMBL19260518 | 0.69 | PYGB (0.40) | PYGLPYGBPYGMSLC5A2SLC5A1 | |
| SCHEMBL28689045 | 0.68 | PYGB (0.40) | PYGLPYGBPYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2217337-B1 | FLUOROALKENYL POLY(1,6)GLYCOSIDES | TYCO FIRE PRODUCTS LP (US) | 2016-07-20 | — | — | EP | disclosed |
| US-8298436-B2 | Fluoroalkenyl poly[1,6]glycosides | ANSUL, INCORPORATED (US) | 2012-10-30 | — | — | US | disclosed |
| EP-2217337-A2 | FLUOROALKENYL POLY(1,6)GLYCOSIDES | Ansul, LLC (US) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009052088-A2 | FLUOROALKENYL POLY [1,6]GLYCOSIDES | ANSUL INCORPORATED (US) | 2009-04-23 | — | — | WO | disclosed |
| US-20090095936-A1 | Fluoroalkenyl Poly[1,6]glycosides | TYCO FIRE PRODUCTS LP | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090095936-A1 | Fluoroalkenyl Poly[1,6]glycosides | AFF1, FRG1, AFF2 | CA1 3225/4885CA2 4442/4885CA7 1399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.